FHIR R4 Resource: Definition and Structure of Medicinal Product

Details

This page serves as the detailed technical specification for the 'MedicinalProductPharmaceutical' resource within the FHIR R4 standard. It is designed to structure comprehensive information regarding pharmaceutical products, going beyond mere names to include details on composition (ingredient), administration form (administrableDoseForm), and usage restrictions or recommendations. Specifically, in addition to defining identifiers, it allows for linking ingredients and associated medical devices. Furthermore, quantitative data—such as the first dose (firstDose), maximum daily dose (maxDosePerDay), and treatment period (maxTreatmentPeriod)—can be structured using Quantity and Duration types, which are crucial for clinical trial reporting. Moreover, it comprehensively defines specialized information such as the route of administration (routeOfAdministration) and withdrawal periods (withdrawalPeriod) for animal products. This structure provides a foundational model for healthcare institutions to manage and exchange pharmaceutical data in a standardized format within electronic health records and information systems, making it a critical reference specification for advancing advanced medical DX in Japan.